Workflow
Kymera Therapeutics (KYMR) Presents At Ligase Targeting Drug Development Summit - Slideshow

May 25-27, 2021 Ligase Targeting DrugDevelopment Seize the Therapeutic Value of Ubiquitin Ligases Drugging Tissue-Restricted E3 Ligases | --- | --- | --- | --- | --- | |-------|-------|-------|-------|---------------------------------------------------------------| | | | | | | | | | | | Chris De Savi, PhD | | | | | | VP, Head of Drug Discovery | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | INVENTING NEW MEDICINES | | | | | | W I T H T A R G E T E D P R O T E I N D E G R ...